Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tissue factor (TF) is the cellular receptor for plasma protease factor VIIa (FVIIa), and the TF-FVIIa complex initiates coagulation in both hemostasis and thrombosis. Cell surface-exposed TF is mainly cryptic and requires activation to fully exhibit the procoagulant potential. Recently, the
protein disulfide isomerase
(
PDI
) has been hypothesized to regulate TF decryption through the redox switch of an exposed disulfide in TF extracellular domain. In this study, we analyzed
PDI
contribution to coagulation using an in vitro endothelial cell model. In this model, extracellular
PDI
is detected by imaging and flow cytometry. Inhibition of cell surface
PDI
induces a marked increase in TF procoagulant function, whereas exogenous addition of
PDI
inhibits TF decryption. The coagulant effects of
PDI
inhibition were sensitive to annexin V treatment, suggesting exposure of phosphatidylserine (PS), which was confirmed by prothrombinase assays and direct labeling. In contrast, exogenous
PDI
addition enhanced PS internalization. Analysis of fluorescent PS revealed that
PDI
affects both the apparent
flippase
and floppase activities on endothelial cells. In conclusion, we identified a new mechanism for
PDI
contribution to coagulation on endothelial cells, namely, the regulation of PS exposure, where
PDI
acts as a negative regulator of coagulation.
...
PMID:Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. 2044 8